Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Apr;29(4):391–395. doi: 10.1111/j.1365-2125.1990.tb03655.x

Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.

P Allain 1, Y Mauras 1, N Krari 1, J Duchier 1, A Cournot 1, J Larcheveque 1
PMCID: PMC1380107  PMID: 2328192

Abstract

1. Sucralfate (basic sucrose aluminium sulphate), a topical intestinal agent, was administered in suspension or granule form to 25 healthy subjects at a total dose of 4 g day-1 for 21 days. Aluminium in plasma and 24 h urine samples was assayed before, during and after administration of sucralfate by inductively coupled plasma optical emission spectrometry. 2. Sucralfate produced significant increases in plasma and urine aluminium concentrations. On average, plasma aluminium increased from about 2 micrograms 1-1 to more than 5 micrograms 1-1 and 24 h urine aluminium increased from less than 5 micrograms to more than 30 micrograms. Both plasma and urine aluminium concentrations decreased rapidly after sucralfate was stopped. However, urinary aluminium concentrations remained higher than normal 5 and 10 days after discontinuation of sucralfate administration. Moreover subjects receiving sucralfate granules had significantly higher average urinary excretion of aluminium than subjects receiving the suspension. 3. The small but significant increase in plasma and urine aluminium following sucralfate administration in therapeutic doses may reflect intestinal absorption of aluminium. Although such absorption would appear to be moderate in healthy subjects, it is suggested that aluminium-based treatments should be used only intermittently, especially in patients with renal disorders.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman F. R., Gitelman H. J. Improved electrothermal determination of aluminum in serum by atomic absorption spectroscopy. Clin Chem. 1980 Feb;26(2):258–260. [PubMed] [Google Scholar]
  2. Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
  3. Allain P., Mauras Y. Determination of aluminum in blood, urine, and water by inductively coupled plasma emission spectrometry. Anal Chem. 1979 Nov;51(13):2089–2091. doi: 10.1021/ac50049a008. [DOI] [PubMed] [Google Scholar]
  4. Allain P., Thebaud H. E., Dupouet L., Coville P., Pisant M., Spiesser J., Alquier P. Etude des taux sanguins de quelques métaux (Al, Mn, Cd, Pb, Cu, Zn) chez les hémodialysés chroniques avant et aprés dialyse. Nouv Presse Med. 1978 Jan 14;7(2):92–96. [PubMed] [Google Scholar]
  5. Boukari M., Rottembourg J., Jaudon M. C., Clavel J. P., Legrain M., Galli A. Influence de la prise prolongée de gels d'alumine sur les taux sériques d'aluminium chez les patients atteints d'insuffisance rénale chronique. Nouv Presse Med. 1978 Jan 14;7(2):85–88. [PubMed] [Google Scholar]
  6. Cartier F., Allain P., Gary J., Chatel M., Menault F., Pecker S. Encéphalopathie myoclonique progressive des dialysés. Rôle de l'eau utilisée pour l'hémodialyse. Nouv Presse Med. 1978 Jan 14;7(2):97–102. [PubMed] [Google Scholar]
  7. Haram E. M., Weberg R., Berstad A. Urinary excretion of aluminium after ingestion of sucralfate and an aluminium-containing antacid in man. Scand J Gastroenterol. 1987 Jun;22(5):615–618. doi: 10.3109/00365528708991908. [DOI] [PubMed] [Google Scholar]
  8. Kaehny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med. 1977 Jun 16;296(24):1389–1390. doi: 10.1056/NEJM197706162962407. [DOI] [PubMed] [Google Scholar]
  9. Kinoshita H., Kumaki K., Nakano H., Tsuyama K., Nagashima R., Okada M., McGraw B. Plasma Aluminum levels of patients on long term sucralfate therapy. Res Commun Chem Pathol Pharmacol. 1982 Mar;35(3):515–518. [PubMed] [Google Scholar]
  10. Kirschbaum B. B., Schoolwerth A. C. Hyperaluminaemia associated with oral citrate and aluminium hydroxide. Hum Toxicol. 1989 Jan;8(1):45–47. doi: 10.1177/096032718900800108. [DOI] [PubMed] [Google Scholar]
  11. Kostyniak P. J. An electrothermal atomic absorption method for aluminum analysis in plasma: identification of sources of contamination in blood sampling procedures. J Anal Toxicol. 1983 Jan-Feb;7(1):20–23. doi: 10.1093/jat/7.1.20. [DOI] [PubMed] [Google Scholar]
  12. Mauras Y., Renier J. C., Tricard A., Allain P. Mise en évidence de l'absorption gastro-intestinale du silicium à partir d'un alumino-silicate. Therapie. 1983 Mar-Apr;38(2):175–178. [PubMed] [Google Scholar]
  13. Oster O. The aluminium content of human serum determined by atomic absorption spectroscopy with a graphite furnace. Clin Chim Acta. 1981 Jul 18;114(1):53–60. doi: 10.1016/0009-8981(81)90227-8. [DOI] [PubMed] [Google Scholar]
  14. Pai S., Melethil S., Cuddy P., Hall T. Elevation of serum aluminum in humans on a two-day sucralfate regimen. J Clin Pharmacol. 1987 Mar;27(3):213–215. doi: 10.1002/j.1552-4604.1987.tb02187.x. [DOI] [PubMed] [Google Scholar]
  15. Recker R. R., Blotcky A. J., Leffler J. A., Rack E. P. Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med. 1977 Nov;90(5):810–815. [PubMed] [Google Scholar]
  16. Slanina P., Frech W., Ekström L. G., Löf L., Slorach S., Cedergren A. Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem. 1986 Mar;32(3):539–541. [PubMed] [Google Scholar]
  17. Versieck J., Cornelis R. Measuring aluminum levels. N Engl J Med. 1980 Feb 21;302(8):468–469. doi: 10.1056/NEJM198002213020818. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES